Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-26 00:58:18 UTC |
---|
Update Date | 2016-11-09 01:18:49 UTC |
---|
Accession Number | CHEM029158 |
---|
Identification |
---|
Common Name | Olomoucine |
---|
Class | Small Molecule |
---|
Description | A 9H-purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor. |
---|
Contaminant Sources | |
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine | ChEBI | 2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine | ChEBI | 2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-ethanol | ChEBI | 2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol | ChEBI | 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine | ChEBI | Olomucine | ChEBI | 2-(2-hydroxyethylamino)-6-benzylamino-9-Isopropylpurine | HMDB | 2-(2-hydroxyethylamino)-6-benzylamino-9-Methylpurine | HMDB | 2-[[9-Methyl-6-(phenylmethylamino)purin-2-yl]amino]ethanol | HMDB | 2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]ethanol, 9ci | HMDB | 4ERK | HMDB | 6-benzylamino-2-(2-hydroxyethylamino)-9-Methylpurine | HMDB | 6-benzylamino-2-[2-hydroxyethylamino]-9-Methylpurine | HMDB | OLO | HMDB | Olomoucine | MeSH |
|
---|
Chemical Formula | C15H18N6O |
---|
Average Molecular Mass | 298.343 g/mol |
---|
Monoisotopic Mass | 298.154 g/mol |
---|
CAS Registry Number | 101622-51-9 |
---|
IUPAC Name | 2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol |
---|
Traditional Name | olomoucine |
---|
SMILES | CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20) |
---|
InChI Key | GTVPOLSIJWJJNY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as 6-alkylaminopurines. 6-alkylaminopurines are compounds that contain an alkylamine group attached at the 6-position of a purine. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Imidazopyrimidines |
---|
Sub Class | Purines and purine derivatives |
---|
Direct Parent | 6-alkylaminopurines |
---|
Alternative Parents | |
---|
Substituents | - 6-alkylaminopurine
- Benzylamine
- Aminopyrimidine
- Secondary aliphatic/aromatic amine
- Monocyclic benzene moiety
- N-substituted imidazole
- Pyrimidine
- Benzenoid
- Imidolactam
- Imidazole
- Azole
- Heteroaromatic compound
- Secondary amine
- Alkanolamine
- Azacycle
- Organopnictogen compound
- Amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0296-2090000000-727de3d1c16675ee79b2 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9053000000-be27d1ff5e6080c227d2 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0002-3090000000-1a02264f7a6e067bfaea | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0006-9270000000-fbf772cf21b5b70b8208 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-9110000000-b29b8eb3b1deb6b72744 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0f6t-1190000000-108ec4094423e5802cc8 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0pdj-2390000000-9d870540cc384c401f0f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-01ox-4940000000-9d99195d8bd1c2d5919b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-0090000000-757aac0df42d659226cb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0fr2-0090000000-54cf210982df3c3bde73 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0h0c-0960000000-f200ec48abef04eb8723 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0002-0090000000-b472d91c0103cb9c1130 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0002-2090000000-22237306b326fad76387 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01ox-6790000000-6d7faa5ffb62ef3ef98e | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB02116 |
---|
HMDB ID | HMDB0035233 |
---|
FooDB ID | FDB013890 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | CPD-5442 |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Glial scar |
---|
Chemspider ID | 4431 |
---|
ChEBI ID | 44661 |
---|
PubChem Compound ID | 4592 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. https://www.ncbi.nlm.nih.gov/pubmed/?term=12147712 | 2. https://www.ncbi.nlm.nih.gov/pubmed/?term=17094472 | 3. https://www.ncbi.nlm.nih.gov/pubmed/?term=18385789 | 4. https://www.ncbi.nlm.nih.gov/pubmed/?term=19723061 | 5. https://www.ncbi.nlm.nih.gov/pubmed/?term=25422646 | 6. https://www.ncbi.nlm.nih.gov/pubmed/?term=27241721 | 7. https://www.ncbi.nlm.nih.gov/pubmed/?term=27345388 | 8. https://www.ncbi.nlm.nih.gov/pubmed/?term=7523194 | 9. https://www.ncbi.nlm.nih.gov/pubmed/?term=7549905 | 10. https://www.ncbi.nlm.nih.gov/pubmed/?term=7925396 | 11. Smejkal K, Svacinova J, Slapetova T, Schneiderova K, Dall'acqua S, Innocenti G, Zavalova V, Kollar P, Chudik S, Marek R, Julinek O, Urbanova M, Kartal M, Csollei M, Dolezal K: Cytotoxic activities of several geranyl-substituted flavanones. J Nat Prod. 2010 Apr 23;73(4):568-72. doi: 10.1021/np900681y. | 12. Fei XF, Qin ZH, Xiang B, Li LY, Han F, Fukunaga K, Liang ZQ: Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Res. 2009 Apr 6;1264:85-97. doi: 10.1016/j.brainres.2009.01.057. Epub 2009 Feb 6. | 13. Papazisis KT, Geromichalos GD, Kouretas D, Dimitriadis KA, Kortsaris AH: CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to cytosine-arabinoside. Cancer Lett. 1999 Apr 26;138(1-2):221-6. | 14. Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC. |
|
---|